Pilot Observational Study of an Integrative Cure Stay Program
University Hospital, Basel, Switzerland
30 participants
Oct 6, 2025
OBSERVATIONAL
Conditions
Summary
This pilot observational study evaluates the feasibility and acceptability of conducting a prospective study alongside the individualized integrative oncology cure stay program "Via Shalva" for breast and gynecological cancer survivors. The study further explores preliminary changes in patient-reported outcomes, physiological measures, and biological markers before and after the retreat and compared with a matched control group.
Eligibility
Inclusion Criteria11
- Breast and gynecological cancer (including but not limited to ovarian, endometrial, cervical, vulvar and vaginal cancer) survivors, including recurrent disease
- Completed primary treatment (operation +/- radiation +/- chemotherapy)
- Age ≥ 18 years
- Ongoing or planned maintenance treatment scheduled for \> 3 months during study period is allowed (e.g. antihormonal therapy, Anti-Her2-antibodies, CDK4/6-inhibitors, Anti-VEGF-inhibitor, PARP-inhibitor, immune-checkpoint inhibitors etc.)
- Signed informed consent for participation of the trials
- Presence of a stoma is allowed
- Prior cancer is allowed
- Prior treatment - including chemotherapy - for a prior malignant tumor (including breast or gynecological cancer) is allowed
- Concomitant participation in an experimental therapeutic drug trial is allowed
- Use of other complementary methods (including mistletoe) is allowed
- Pregnancy is allowed.
Exclusion Criteria3
- Language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study
- Severe physical or psychiatric comorbidity that prevents a patient from participating in the study
- Patients incapable of giving consent
Interventions
Participants attend a 7-day integrative oncology retreat including individualized consultations, complementary therapies, and group-based mind-body interventions
Participants receive usual oncology follow-up without attending the retreat
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07398079